New Diet Pill Approved by Fda

FDA will reconsider decision barring copycat versions of Lilly weight loss drug

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding

The Washington Post · 11d

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug Administration announced Wednesday.

The Motley Fool on MSN · 8h

Should Eli Lilly Investors Worry About This Unexpected FDA Move?

All of this means Lilly investors shouldn't panic. Even in the "worst case," Lilly's weight loss drugs have driven major revenue growth, and this is likely to continue -- whether compounders halt sales soon or a bit farther down the road.

23h

FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...

STAT3h

A controversial approval for Novocure’s device

The FDA yesterday the approval of Novocure’s Optune device to include the treatment of metastatic non-small cell lung cancer.

22h

Drugmakers can keep making off-brand weight-loss drugs as FDA backpedals

Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...

Everyday Health19h

Are Compounded Weight Loss Drugs on Their Way Out?

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

6hon MSN

Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

14h

Experimental ALS drug could offer new hope for patients if approved, researchers say

New hope could be on the horizon for ALS patients in the form of a “breakthrough" drug, researchers say. Neuvivo is seeking approval for an experimental medication for the neurological condition.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results